Prevention and Treatment of Hepatitis Virus Infections in Hematopoietic Stem Cell Transplant Recipients

Abstract

Infections with Hepatitis viruses B and C pose major problems both short and long term respectively after HSCT. The key to prevention for Hepatitis B disease remains vaccination for HBV-naïve patients and judicial use of anti-viral therapy in both pre- and post-transplant settings for HBV-infected patients. HBsAg positive grafts to HBV-naïve recipients… (More)
DOI: 10.4084/MJHID.2009.017

7 Figures and Tables

Topics

  • Presentations referencing similar topics